---  
layout: startup_page  
title: "Nammi Therapeutics"  
id: "nammirx.com"  
permalink: "/nammitherapeuticsnammirx.com08062024/"  
website: "https://www.nammirx.com/"  
funding_round: "Series B"  
funding_amount: "$30M"  
investors: "Myeloma Investment Fund (MIF)"  
about: "Nammi Therapeutics is an immuno-oncology company developing platforms and products that selectively activate anti-tumor immunity within the tumor microenvironment while minimizing systemic activation. They are focused on improving safety and combining multiple immune modulators through their Masked Immunocytokine (MIC) and nanoparticle platforms. This approach aims to enhance the efficacy of cancer treatments."  
markets: "Immuno-oncology, Biotechnology, Drug Discovery, Life Sciences, Oncology"  
hq: "Los Angeles, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/nammi-therapeutics-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nammi-therapeutics?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/464197-33"  

date_display: "06-Aug-2024"  
date: "2024-08-06"

# SEO Optimization  
meta_title: "Nammi Therapeutics - Series B Funding ($30M)"  
meta_description: "Nammi Therapeutics, Nammi Therapeutics is an immuno-oncology company developing platforms and products that selectively activate anti-tumor immunity within the tumor micr..."  
meta_keywords: "Nammi Therapeutics, Immuno-oncology, Biotechnology, Drug Discovery, Life Sciences, Oncology, Series B funding"  
canonical_url: "https://startup.projectstartups.com/nammitherapeuticsnammirx.com08062024/"  
---